drugset / Trial / NCT00221442
Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
Phase 3
Completed
60 enrolled
Lindner Center of HOPE
Eisai Inc. · collabUniversity of Cincinnati · collab
RandomizedSingle-groupTriple-blindTreatment
Summary
The specific aim of this study is to examine the efficacy and safety of zonisamide compared with placebo in outpatients with binge eating disorder associated with obesity.
Timeline
- Start
- 2005-08
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Zonisamide | Other / unclassified | — | — |